June 28, 2022 Certara Introduces New Simcyp™ Discovery Simulator for Early-Stage and Translational Drug Development
June 21, 2022 Certara Announces New Versions of Biosimulation Software for Development of Novel Biologics
February 15, 2022 Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 8th Consecutive Year
February 8, 2022 Certara to Report Fourth Quarter and Full Year 2021 Financial Results on March 1st, 2022